Back to Authors

Parfionovas, Andrejus

A5045814391 | I4210140176

Mayo Clinic

Takeda Pharmaceuticals, Cambridge, USA

Citations 1

OP26 Long-term safety of vedolizumab in ulcerative colitis and Crohn’s disease: final results from the GEMINI LTS study

Journal of Crohn's and Colitis | January 25, 2019 | Volume: 13 | Issue: Supplement_1 | Pages: S018-S020

10.1093/ecco-jcc/jjy222.025